🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an Open-label, multicenter clinical study conducted in two Phases t...
Status
Active Not Recruiting
Location
UCLA Hematology and Oncology - Santa Monica
Start Date
2023-09-13
Trial ID
NCT05882734
Treatments Being Tested
This phase II trial compares tuvusertib in combination with avelumab to tuv...
Status
Active Not Recruiting
Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Start Date
2024-05-21
Trial ID
NCT05947500
Background: Chemotherapy damages cancer cell deoxyribonucleic acid (DNA) s...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2015-07-30
Trial ID
NCT02487095
Treatments Being Tested
The purpose of this study is to investigate the ability of vibrational spec...
Status
Unknown
Location
Nottingham University Hospitals NHS Trust
Start Date
2020-01-19
Trial ID
NCT05026073
Our aim is to study the effect of art therapy for people with PSP, with a f...
Status
Active Not Recruiting
Location
Vanderbilt University Medical Center
Start Date
2025-01-14
Trial ID
NCT06588673
Treatments Being Tested
Investigational agent, AZD6738 will be given in combination with Olaparib t...
Status
Completed
Location
Johns Hopkins University School of Medicine
Start Date
2018-03-09
Trial ID
NCT03462342
Treatments Being Tested
The homologous recombination deficiency (HRD) status in Chinese population ...
Status
Unknown
Location
Lei Li
Start Date
2019-12-07
Trial ID
NCT04190667
Treatments Being Tested
This phase I trial tests the safety, side effects, and best dose of camonse...
Status
Recruiting
Location
UPMC Hillman Cancer Center
Start Date
2027-02-13
Trial ID
NCT07156227
This research study is studying a checkpoint kinase 1 (CHK1) inhibitor as a...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2016-10-12
Trial ID
NCT02873975
Treatments Being Tested
The primary purpose of this study is to assess the safety and tolerability ...
Status
Recruiting
Location
# 1019, UCLA, Westwood Cancer Center
Start Date
2021-04-30
Trial ID
NCT04855656
Treatments Being Tested